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Molecular basis of disease: Arterial hypertensionDr. Wilhelm Schoner is Professor Emeritus of Biochemistry
at the Institute of Biochemistry and Endocrinology of the
Justus-Liebig-University Giessen. He studied medicine,
receiving his medical degree on 1962 at the Johannes-
Gutenberg-University of Mainz. This was followed by seven
years of training in biochemistry at the universities of
Frankfurt/M and Göttingen, where he obtained his habili-
tation in biochemistry in 1969. From 1972 to 2003 he was
professor and chairman of the above institute in Giessen.
His research focused on the mechanism of the sodium
pump, and by the use of ﬂuorescent and substitution-inert
Mg-ATP analogs, he was able to conclude that sodium
pumping needs the cooperation of catalytic α subunits in
this process. In investigating the biological role of cardiac glycosides as speciﬁc
inhibitors of the sodium pump, he isolated ouabain from bovine adrenal glands and
veriﬁed its structure. Moreover, he realized that blood levels of endogenous ouabain
can become elevated within minutes upon physical exercise and also drops rapidly
upon rest, thus supporting the concept that a compound heretofore only recognized as
a plant toxin can act as an endogenous mammalian steroid hormone regulating blood
pressure and heart function.Human arterial hypertension is a complex, multifactorial quanti-
tative trait under polygenic control. Candidate genes involved in
primary arterial hypertension have been identiﬁed in the last 20
years. They are mostly implicated in mechanisms of sodium
metabolism and its regulation. Long-term excess of dietary sodium
has been known for a long time to cause arterial hypertension. The
body's sodium accumulation causes water retention in order to
maintain physiological osmolarity of bodily ﬂuids and cellular volume.
Interestingly, some recent ﬁndings indicate that intracellular osmo-
larity is sensed by protein kinases measuring intracellular concentra-
tions of Na+ and Cl­ such as SIK1 and WNK kinases. They may
modulate active sodium transport and cause numerous hormonal
responses.
The body's control of Na+ metabolism is achieved mainly by the
kidney, and hence the number of nephrons of an individual as control
units of sodium metabolism as well as proteins and hormones
regulating renal transepithelial Na+ and ﬂuid metabolism are
important regulatory criteria. Recent analysis of various monogenic
forms of essential hypertension led to a more fundamental under-
standing of the disease by the identiﬁcation of proteins and their
hormonal control systems involved in renal Na+ metabolism.
Evidently, not only mutations of the apical renal tubular Na+ channels
(EnaC) and of the proteins of the intracellular hormone signaling
machinery may lead to hypertension, but also defects of intracellular
trafﬁcking and turnover of the proteins. More recently, the important
role of the basolaterally located renal sodium pumps in regulating the
transepithelial tubular Na+ transport of kidneys has come into the
focus of research. In particular, the discovery of endogenous cardiac
glycosides as new steroid hormones that induce hypertension and use
the sodium pump as a hormone receptor sheds a new light on the
disease. This cardiotonic steroid hormone system is intimately linked
to the renin–angiotensin–aldosterone and adrenergic systems. An
unexpected discovery was the ﬁnding that the cardiac glycoside
receptor site acts as a signal transducer at concentrations of
endogenous cardiac glycosides that are not inhibitory toward the
sodium pump. This transducing and signaling system is interlinked
with other blood pressure-regulating hormonal systems. Defects in
the internalization of the cardiac glycoside receptor by a defective
renal cytoskeleton due to a mutation of the cytoskeletal protein
adducin were discovered to be a cause of monogenetic hypertension,
showing again that alterations of trafﬁcking of membrane proteins are
important. The successful search for ouabain antagonists to treat0925-4439/$ – see front matter © 2010 Published by Elsevier B.V.
doi:10.1016/j.bbadis.2010.10.003hypertension may have opened up a new principle of antihyperten-
sive therapy.
This collection of reviews by leading scientists in the ﬁeld reports
on the signal transduction mechanisms of blood pressure-regulating
hormones and how alterations lead to vascular contraction and, as a
consequence of the ensuing hypertension, to an alteration of the
function of endothelial cells, effects on nutritional transport through
the placenta, loss of function of renal glomeruli, remodeling of the
heart, and an altered hormonal control system of Na+ metabolism in
the brain.
I am most grateful to all the contributors and reviewers for their
efforts in making this special issue a reality. My sincere thanks to the
BBA staff for my endowment with this task to assemble reviews from
leading laboratories in this special issue and to Jeff Rossetti for his
professional support during the task.
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